When testing Japanese drug from COVID-19 problems

При испытании японского препарата от COVID-19 возникли проблемы

All the news on the map

The Japanese authorities will not be able to approve in may the preparation of local manufacture “Avigan” for the treatment of people infected with coronavirus SARS-CoV-2. In clinical trials, researchers of the island nation was unable to confirm the effectiveness of a therapeutic agent in fighting infection, reports broadcaster NHK.

According to some, in clinical trials “Avigan” attended by 86 people infected with coronavirus. The disease occurs in mild form or in the absence of symptoms.

Rambler without ads

People previously divided into two groups. Some patients began receiving the drug on the first day of admission to the hospital, the other from the sixth. With tangible difference in their condition were recorded. Thus, the observation suggests that the use of “Avigan” had no effect on recovery infected.

Earlier, the official Tokyo decided on a Pro Bono basis to send “Avian” in a number of foreign countries. The list contains about 80 countries.

Video of the day. Lost her husband scandalous blogersha increased breast


Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button

Please disable your ad blocker

We know you are here for the stories. Not the ads. But we need the ads to keep the lights on. So please whitelist
Cookie Box Settings